Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.4M
-
Number of holders
-
339
-
Total 13F shares, excl. options
-
25.8M
-
Shares change
-
-582K
-
Total reported value, excl. options
-
$4.05B
-
Value change
-
-$88.3M
-
Put/Call ratio
-
0.34
-
Number of buys
-
152
-
Number of sells
-
-167
-
Price
-
$157.17
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q3 2022
375 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q3 2022.
Medpace Holdings, Inc. - Common Stock (MEDP) has 339 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.8M shares
of 28.4M outstanding shares and own 90.65% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.03M shares), VANGUARD GROUP INC (2.77M shares), WASATCH ADVISORS INC (2.16M shares), STATE STREET CORP (822K shares), FULLER & THALER ASSET MANAGEMENT, INC. (814K shares), Invesco Ltd. (730K shares), Boston Trust Walden Corp (699K shares), Echo Street Capital Management LLC (652K shares), DIMENSIONAL FUND ADVISORS LP (626K shares), and GEODE CAPITAL MANAGEMENT, LLC (534K shares).
This table shows the top 339 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.